Moderna Inc. closed $127.61 below its 52-week high ($170.47), which the company achieved on May 24th.

The FDA flagged at least five cases of severe or very severe RSV lower respiratory tract infections in infants immunized with ...

MinterEllison has advised Moderna in relation to its new mRNA manufacturing facility – a facility described by the firm as ...

On Tuesday, Moderna Inc (MRNA) stock saw a decline, ending the day at $41.51 which represents a decrease of $-4.14 or -9.07% from the prior close of $45.65. The stock opened at $45.36 and touched a ...

MicroStrategy could join the Nasdaq 100, replacing Moderna. Its Bitcoin investments fuel growth while tech classification circumvents rules.

A new mRNA therapy tested in mice may target the root cause of the potentially fatal pregnancy disorder preeclampsia. It's ...

When asked whether his fourth Senate term would be his last, Sanders (I-Vt.) said: “I’m 83 now. I’ll be 89 when I get out of ...

A third dose of COVID-19 vaccine is beneficial among older Medicare beneficiaries, regardless of prior medically attended COVID-19 diagnoses.

Updated figures from the WHO show that more than one in five adults aged between 15 and 49 globally have the infection.

Operation Warp Speed's COVID vaccine is arguably the greatest accomplishment of Trump's first term, but he has turned his ...

Fox News health commentator Dr. Kelly Powers was diagnosed with glioblastoma, an aggressive form of brain cancer, in July 2020, months before COVID-19 vaccines were made available in the U.S. But ...

A briefing document from the Food and Drug Administration (FDA) says that enrollment for all clinical studies of vaccines for ...